Patents by Inventor Scott A. Springer

Scott A. Springer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230046040
    Abstract: Methods, devices, and systems are provided that determine analyte trends according to different methods depending on whether a change-resistant state is active or not active. The method used when the change-resistant state is activated provides for different requirements for a resulting analyte trend to transition between states (e.g., level to non-level). Furthermore, in some aspects, methods, devices, and systems of selecting or modifying a response rate of an analyte monitoring device for an individual user are provided. User instructions for selecting or modifying a response rate of the device or system is received externally via a user interface or communication channel. The response rate of the analyte monitoring device or system is then selected or modified to the first response rate, and the device or system operated with the first response rate.
    Type: Application
    Filed: August 22, 2022
    Publication date: February 16, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Kenneth J. Doniger, Gary A. Hayter, Scott A. Springer, Geoffrey V. McGarraugh
  • Patent number: 11424015
    Abstract: Methods, devices, and systems are provided that determine analyte trends according to different methods depending on whether a change-resistant state is active or not active. The method used when the change-resistant state is activated provides for different requirements for a resulting analyte trend to transition between states (e.g., level to non-level). Furthermore, in some aspects, methods, devices, and systems of selecting or modifying a response rate of an analyte monitoring device for an individual user are provided. User instructions for selecting or modifying a response rate of the device or system is received externally via a user interface or communication channel. The response rate of the analyte monitoring device or system is then selected or modified to the first response rate, and the device or system operated with the first response rate.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: August 23, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Kenneth J. Doniger, Gary A. Hayter, Scott A. Springer, Geoffrey V. McGarraugh
  • Publication number: 20190035493
    Abstract: Methods, devices, and systems are provided that determine analyte trends according to different methods depending on whether a change-resistant state is active or not active. The method used when the change-resistant state is activated provides for different requirements for a resulting analyte trend to transition between states (e.g., level to non-level). Furthermore, in some aspects, methods, devices, and systems of selecting or modifying a response rate of an analyte monitoring device for an individual user are provided. User instructions for selecting or modifying a response rate of the device or system is received externally via a user interface or communication channel. The response rate of the analyte monitoring device or system is then selected or modified to the first response rate, and the device or system operated with the first response rate.
    Type: Application
    Filed: October 3, 2018
    Publication date: January 31, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Kenneth J. Doniger, Gary A. Hayter, Scott A. Springer, Geoffrey V. McGarraugh
  • Patent number: 10108781
    Abstract: Methods, devices, and systems are provided that determine analyte trends according to different methods depending on whether a change-resistant state is active or not active. The method used when the change-resistant state is activated provides for different requirements for a resulting analyte trend to transition between states (e.g., level to non-level). Furthermore, in some aspects, methods, devices, and systems of selecting or modifying a response rate of an analyte monitoring device for an individual user are provided. User instructions for selecting or modifying a response rate of the device or system is received externally via a user interface or communication channel. The response rate of the analyte monitoring device or system is then selected or modified to the first response rate, and the device or system operated with the first response rate.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: October 23, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Kenneth J. Doniger, Gary A. Hayter, Scott A. Springer, Geoffrey V. McGarraugh
  • Publication number: 20140095081
    Abstract: Methods, devices, and systems are provided that determine analyte trends according to different methods depending on whether a change-resistant state is active or not active. The method used when the change-resistant state is activated provides for different requirements for a resulting analyte trend to transition between states (e.g., level to non-level). Furthermore, in some aspects, methods, devices, and systems of selecting or modifying a response rate of an analyte monitoring device for an individual user are provided. User instructions for selecting or modifying a response rate of the device or system is received externally via a user interface or communication channel. The response rate of the analyte monitoring device or system is then selected or modified to the first response rate, and the device or system operated with the first response rate.
    Type: Application
    Filed: September 27, 2013
    Publication date: April 3, 2014
    Inventors: Kenneth J. Doniger, Gary A. Hayter, Scott A. Springer, Geoffrey V. McGarraugh